Patent · US Active

Maize event MON87429 and methods of use thereof

US10920239B2 · kind B2 · utility

2Cited by

11References

19Claims

0Family size

Assignee

Monsanto Technology LLC · US

Inventors

Christine M. Ellis · Chesterfield, US
Michael E. Goley · Chesterfield, US
Jintai Huang · Chesterfield, US
Tracy E. Klingaman · Holden, US
Clayton T. Larue · Chesterfield, US
Youlin Qi · Chesterfield, US
Oscar C. Sparks · Chesterfield, US
Brook M. Van Scoyoc · O'Fallon, US
Heping Yang · Shanghai, CN

Key dates

Filing date	Jan 28, 2019
Grant date	Feb 16, 2021
Priority date	—
Expiry date	Feb 28, 2039

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A40/146
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention provides recombinant DNA molecules that are unique to maize event MON87429 and transgenic maize plants, maize plant parts, maize seeds, maize cells, and agricultural products containing maize event MON87429 as well as methods of using and detecting maize event MON87429. Transgenic maize plants containing maize event MON87429 exhibit tolerance to inhibitors of acetyl CoA carboxylase (ACCase) in the aryloxyphenoxy propionate (FOP) group, synthetic auxins, inhibitors of glutamine synthetase, and inhibitors of 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.